The roles of IL-12 and IL-23 in CD8+ T cell-mediated immunity against Listeria monocytogenes: Insights from a DC vaccination model
Authors:
- 31 December 2010
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 264 (1) , 23-31
Abstract
No abstract availableKeywords
Funding Information
- NIH (AI057770-01A1, AI73245-01A1)
This publication has 62 references indexed in Scilit:
- Interleukin-17 Is Required for T Helper 1 Cell Immunity and Host Resistance to the Intracellular Pathogen Francisella tularensisImmunity, 2009
- Effects of Signal 3 during CD8 T cell priming: Bystander production of IL-12 enhances effector T cell expansion but promotes terminal differentiationVaccine, 2009
- Dendritic Cells: A Critical Player in Cancer Therapy?Journal of Immunotherapy, 2008
- From interleukin‐23 to T‐helper 17 cells: human T‐helper cell differentiation revisitedImmunological Reviews, 2008
- Immunotherapy of cancer by IL-12-based cytokine combinationsExpert Opinion on Biological Therapy, 2007
- Inflammation Directs Memory Precursor and Short-Lived Effector CD8+ T Cell Fates via the Graded Expression of T-bet Transcription FactorImmunity, 2007
- Memory CD4 T Cells Enhance Primary CD8 T-Cell ResponsesInfection and Immunity, 2007
- Interleukin-12: A master regulatorJournal of Experimental Medicine, 2007
- Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitisJournal of Clinical Investigation, 2006
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003